Systematic review of randomized controlled trials on interventions for melasma: an abridged Cochrane review

Area of Science:

• Dermatology
• Evidence-based medicine
• Pharmacology

Background:

• Melasma treatments are numerous but often suboptimal and carry side effects.
• Current therapeutic options for melasma management require further evaluation.

Purpose of the Study:

• To systematically assess the effectiveness of various interventions for all types of melasma.
• To provide an evidence-based overview of melasma treatment efficacy.

Main Methods:

• A systematic review was conducted following Cochrane Collaboration guidelines.
• Twenty studies involving 2125 participants and 23 treatments were included.
• Meta-analysis was precluded by significant heterogeneity in treatment modalities.

Main Results:

• Triple-combination cream (hydroquinone, tretinoin, fluocinolone acetonide) demonstrated superior efficacy over hydroquinone alone or dual-combination creams.
• 20% azelaic acid was more effective than 2% hydroquinone in lightening melasma.
• Tretinoin showed significant objective improvements in melasma severity compared to placebo, though subjective patient ratings varied.

Conclusions:

• The existing evidence base for melasma interventions is limited by poor study methodology, lack of standardized outcomes, and short study durations.
• While some treatments show promise, high-quality randomized controlled trials with long-term outcome assessments are essential.
• Further research is needed to establish definitive treatment guidelines for melasma.